DOI QR코드

DOI QR Code

Clinical Results of Arteriovenous Fistulas Constructed Using Autologous Vessels in End-Stage Renal Disease Patients on Hemodialysis

  • Kim, Ki Tae (Department of Thoracic and Cardiovascular Surgery, Dankook University College of Medicine) ;
  • Ryu, Jae Wook (Department of Thoracic and Cardiovascular Surgery, Dankook University College of Medicine) ;
  • Seo, Pil Won (Department of Thoracic and Cardiovascular Surgery, Dankook University College of Medicine) ;
  • Ryu, Kyoung Min (Department of Thoracic and Cardiovascular Surgery, Dankook University College of Medicine)
  • Received : 2017.08.18
  • Accepted : 2017.10.11
  • Published : 2018.04.05

Abstract

Background: For hemodialysis patients with end-stage renal disease (ESRD), it is important to construct an efficient vascular access with a superior patency rate. This study investigated the factors influencing the efficiency of arteriovenous fistulas (AVFs) constructed using an autologous vessel and evaluated the necessity of ultrasonography as a preoperative tool for AVF construction. Methods: A retrospective analysis was performed of 250 patients in whom an AVF was constructed using an autologous vessel due to ESRD at our institution from January 2009 to April 2016. Results: The 1-, 3-, and 5-year patency rates for all subjects were 87.6%, 85.6%, and 84.4%, respectively. The patients who underwent a preoperative evaluation of their vessels via ultrasonography had better patency rates than those who did not. Superior patency rates were found in patients under 65 years of age or with an anastomotic vein diameter of 3 mm or more. The 1-year patency rate and the diameter of the anastomotic vein showed a positive relationship. Conclusion: Ultrasonography is strongly recommended for AVF construction, and efforts should be made to increase the patency rate in patients over 65. Superior clinical results can be expected when an AVF is made using an autologous vessel with an anastomotic vein diameter of at least 3 mm.

Keywords

References

  1. Ahn SJ, Choi EJ. Renal replacement therapy in Korea: Insan Memorial Registry 1997. Korean J Nephrol 1999;18:1-15.
  2. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966;275:1089-92. https://doi.org/10.1056/NEJM196611172752002
  3. Kim DS, Kim SW, Kim JC, Cho JH, Kong JH, Park CR. Clinical analysis of hemodialysis vascular access: comparision of autogenous arterioveonus fistula & arteriovenous prosthetic graft. Korean J Thorac Cardiovasc Surg 2011;44:25-31.
  4. Min SK, Ahn JH, Han JJ, Won TH. Factors influencing on early patency rate of autogenous arteriovenous fistula for hemodialysis. Korean J Thorac Cardiovasc Surg 2004;37:342-8.
  5. Yoon YC, Choi BO, Ku BI, et al. Clinical experiences of arteriovenous fistula & associated operations for hemodialysis in 290 cases. Korean J Thorac Cardiovasc Surg 1993;26: 761-8.
  6. Quinton W, Dillard D, Scribner BH. Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 1960;6:104-13.
  7. Wedgwood KR, Wiggins PA, Guillou PJ. A prospective study of end-to-side vs. side-to-side arteriovenous fistulas for haemodialysis. Br J Surg 1984;71:640-2.
  8. Yu JH, Kim JH. Clinical analysis of expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Korean J Thorac Cardiovasc Surg1996;29:883-8.
  9. Wong V, Ward R, Taylor J, Selvakumar S, How TV, Bakran A. Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg 1996;12:207-13. https://doi.org/10.1016/S1078-5884(96)80108-0
  10. Silva MB Jr, Hobson RW 2nd, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998;27:302-7. https://doi.org/10.1016/S0741-5214(98)70360-X
  11. National Kidney Foundation-Dialysis Outcomes Quality Initiative. NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 1997;30(4 Suppl 3):S150-91.